Looking for expert perspective on the recent FDA approval of Centanafadine? Dr. Max Wiznitzer discusses what this new treatment option could mean for children and adults with ADHD. Read the article: https://www.healthline.com/health-news/fda-approves-ndsri-simtriyo-adhd-adults-children #ADHD
ADHD: FDA Approves New CNS Drug Simtriyo for Adults and ChildrenThe Food and Drug Administration (FDA) approved a new "first-in-class" medication to help manage attention deficit hyperactivity disorder (ADHD). SIMTRIYO is a daily tablet authorized for adults and children ages 6 years and older who weigh at least 44 pounds.www.healthline.com